亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology

药物数据库 沃戈宁 UniProt公司 自动停靠 小桶 计算生物学 对接(动物) 汤剂 生物 药理学 传统医学 药品 中医药 生物化学 医学 生物信息学 黄芩 转录组 基因表达 替代医学 护理部 病理 基因
作者
Xiaowen Zhang,Aimin Liu,Jingjing Zhao,Jia Guo,Xinyi Chen,Xiaoxiao Qu
标识
DOI:10.19540/j.cnki.cjcmm.20201117.401
摘要

To study the molecular mechanism of Mahuang Lianqiao Chixiaodou Decoction in the treatment of eczema by means of network pharmacology and molecular docking. First, the TCMSP database was used to excavate the ingredient of each drug in Mahuang Lianqiao Chixiaodou Decoction and predict its target, and the Uniprot database was used to standardize the names of target proteins, in order to obtain the disease of eczema through GeneCards, OMIM, PharmGkb, DrugBank and other databases. And next, the potential on which drug and disease work together were selected to make a Venn diagram, the Cytoscape 3.6.1 software was used to screen out and construct the active ingredient-core targets network. STRING database was used to construct a protein-protein interaction(PPI) network, and the R language was used to perform GO enrichment analysis and KEGG pathway analysis. Finally, the molecular docking verification of main ingredients and core of the drug was performed by AutoDock software. The study showed that 74 ingredients and 103 of Mahuang Lianqiao Chixiaodou Decoction for the treatment of eczema were screened. The main ingredients included quercetin, luteolin, wogonin, kaempferol, and the main included PTGS1, ESR1, PPARG, and MAPK3. In addition, eight key targets, including MAPK8, MAPK3, JUN, MAPK14, TP53, MAPK1, ESR1 and RELA, were calculated by PPI network. GO enrichment analysis involved 2 024 biological processes, 81 cell components, and 140 molecular functions. KEGG pathway enrichment analysis was performed to screen out 158 eczema-related pathways, which mainly acted on AGE-RAGE signaling pathway, IL-17 signaling pathway, virus-related pathways, and the results of molecular docking showed that the main compounds could respectively bind to representative and exhibit a good affinity. The study proved that the treatment of eczema with Mahuang Lianqiao Chixiaodou Decoction involved multiple signaling pathways and biological processes, and the combination of main ingredients(such as quercetin, luteolin, wogonin, kaempferol) and key targets(such as MAPK8, MAPK3, JUN, MAPK14, TP53, MAPK1, ESR1, RELA) may be one of the important mechanisms of action.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
孤蚀月发布了新的文献求助200
刚刚
勿昂完成签到 ,获得积分10
8秒前
江三村完成签到 ,获得积分10
18秒前
25秒前
30秒前
JamesPei应助不懂事的小孩采纳,获得10
35秒前
CipherSage应助Dddql采纳,获得20
50秒前
56秒前
大傻缺发布了新的文献求助400
1分钟前
深情安青应助zhengzh采纳,获得10
2分钟前
2分钟前
追三完成签到 ,获得积分10
2分钟前
饱满金毛发布了新的文献求助10
2分钟前
andrele发布了新的文献求助10
3分钟前
李子木完成签到 ,获得积分10
3分钟前
小二郎应助火星上的万恶采纳,获得10
4分钟前
4分钟前
4分钟前
火星上的万恶完成签到 ,获得积分20
4分钟前
Z2完成签到 ,获得积分10
4分钟前
rofsc完成签到 ,获得积分10
4分钟前
4分钟前
震动的听枫完成签到,获得积分10
5分钟前
孤蚀月关注了科研通微信公众号
5分钟前
执意完成签到 ,获得积分10
5分钟前
winkyyang完成签到 ,获得积分10
5分钟前
assholechea完成签到,获得积分20
5分钟前
Yippee完成签到 ,获得积分10
5分钟前
assholechea发布了新的文献求助10
5分钟前
mrwang完成签到 ,获得积分10
5分钟前
VV完成签到 ,获得积分10
5分钟前
从容苡完成签到,获得积分10
6分钟前
6分钟前
7分钟前
Dddql关注了科研通微信公众号
7分钟前
7分钟前
舒适静丹完成签到,获得积分20
7分钟前
从容苡发布了新的文献求助10
7分钟前
舒适静丹发布了新的文献求助10
7分钟前
JamesPei应助舒适静丹采纳,获得10
7分钟前
高分求助中
Biology and Ecology of Atlantic Cod 1500
LNG地下式貯槽指針(JGA指-107-19)(Recommended practice for LNG inground storage) 1000
Second Language Writing (2nd Edition) by Ken Hyland, 2019 1000
Generalized Linear Mixed Models 第二版 1000
rhetoric, logic and argumentation: a guide to student writers 1000
QMS18Ed2 | process management. 2nd ed 1000
Operative Techniques in Pediatric Orthopaedic Surgery 510
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2922097
求助须知:如何正确求助?哪些是违规求助? 2565434
关于积分的说明 6937169
捐赠科研通 2222168
什么是DOI,文献DOI怎么找? 1181371
版权声明 588852
科研通“疑难数据库(出版商)”最低求助积分说明 577971